| Q47806485 | A disease-associated frameshift mutation in caveolin-1 disrupts caveolae formation and function through introduction of a de novo ER retention signal |
| Q35549729 | A genetic polymorphism in the CAV1 gene associates with the development of bronchiolitis obliterans syndrome after lung transplantation |
| Q42809029 | A high-cholesterol diet increases the association between caveolae and insulin receptors in rat liver |
| Q40541022 | A new rat type I-like alveolar epithelial cell line R3/1: bleomycin effects on caveolin expression |
| Q35073471 | Age-related changes in vascular adrenergic signaling: clinical and mechanistic implications |
| Q39791849 | Altered distribution of caveolin-1 in early liver steatosis. |
| Q48625073 | Ammonium Increases TRPC1 Expression Via Cav-1/PTEN/AKT/GSK3β Pathway |
| Q36343101 | Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis? |
| Q35991319 | Antenatal inflammation reduces expression of caveolin-1 and influences multiple signaling pathways in preterm fetal lungs. |
| Q34886044 | Arf6-independent GPI-anchored protein-enriched early endosomal compartments fuse with sorting endosomes via a Rab5/phosphatidylinositol-3'-kinase-dependent machinery |
| Q26742079 | Assembly and Turnover of Caveolae: What Do We Really Know? |
| Q38112396 | Balancing the fat: lipid droplets and human disease |
| Q37941005 | Biochemical and molecular aspects of vascular adrenergic regulation of blood pressure in the elderly |
| Q40509403 | Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells |
| Q38978258 | Caveolin 1 and G-Protein-Coupled Receptor Kinase-2 Coregulate Endothelial Nitric Oxide Synthase Activity in Sinusoidal Endothelial Cells. |
| Q35057066 | Caveolin-1 and force regulation in porcine airway smooth muscle |
| Q38092213 | Caveolin-1 as a promoter of tumour spreading: when, how, where and why. |
| Q35070726 | Caveolin-1 deficiency (-/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness |
| Q42087664 | Caveolin-1 deficiency induces spontaneous endothelial-to-mesenchymal transition in murine pulmonary endothelial cells in vitro |
| Q35834041 | Caveolin-1 expression is elevated in claudin-low mammary tumor cells |
| Q92228926 | Caveolin-1 gene therapy inhibits inflammasome activation to protect from bleomycin-induced pulmonary fibrosis |
| Q28587327 | Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli |
| Q38977610 | Caveolin-1 limits human influenza A virus (H1N1) propagation in mouse embryo-derived fibroblasts |
| Q35789293 | Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia |
| Q40440532 | Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice |
| Q37307795 | Caveolin-1, transforming growth factor-beta receptor internalization, and the pathogenesis of systemic sclerosis |
| Q35747889 | Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. |
| Q43110613 | Caveolin-1: a new locus for human lipodystrophy |
| Q36253530 | Caveolins and lung function |
| Q36994563 | Caveolins in glial cell model systems: from detection to significance |
| Q33198520 | Changes in membrane cholesterol affect caveolin-1 localization and ICC-pacing in mouse jejunum |
| Q57364636 | Chapter 8 Insulin Signaling and Caveolae |
| Q24553188 | Cholesterol, lipid rafts, and disease |
| Q40573510 | Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a/CAV-1 in mammary epithelial cell hyperplasia |
| Q38560271 | Congenital generalized lipodystrophies--new insights into metabolic dysfunction |
| Q38795317 | DT(270-326) , a Truncated Diphtheria Toxin, Increases Blood-Tumor Barrier Permeability by Upregulating the Expression of Caveolin-1. |
| Q57374668 | Defining lipid raft structure and function with proximity imaging |
| Q40293504 | Differential expression of caveolin-3 in mouse smooth muscle cells in vivo |
| Q41656102 | Differential roles of caveolin-1 in ouabain-induced Na+/K+-ATPase cardiac signaling and contractility |
| Q40102242 | Dispensability and dynamics of caveolin-1 during liver regeneration and in isolated hepatic cells. |
| Q44976854 | Effect of insulin on caveolin-enriched membrane domains in rat liver |
| Q34758224 | Effects of estrogens on the expression of caveolin-1 in the urinary bladders of female rats |
| Q46512858 | Effects of rapamycin on the arterial inflammatory response in atherosclerotic plaques in Apo-E knockout mice. |
| Q52577774 | Endothelial cytoskeletal reorganization in response to PAR1 stimulation is mediated by membrane rafts but not caveolae. |
| Q35057354 | Endothelial nitric oxide synthase: the Cinderella of inflammation? |
| Q24795877 | Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease |
| Q44249820 | Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells |
| Q36278172 | Fleeting glimpses of lipid rafts: how biophysics is being used to track them |
| Q37735126 | From embryonic development to human diseases: The functional role of caveolae/caveolin |
| Q39332149 | Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells. |
| Q37164504 | Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions |
| Q94460598 | Genotype-phenotype correlations of Berardinelli-Seip congenital lipodystrophy and novel candidate genes prediction |
| Q44383460 | Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease |
| Q33770174 | IGF-IR internalizes with Caveolin-1 and PTRF/Cavin in HaCat cells |
| Q44627782 | Identification of novel genes and altered signaling pathways in the retinal pigment epithelium during the Royal College of Surgeons rat retinal degeneration. |
| Q34735669 | Impact of oxLDL on Cholesterol-Rich Membrane Rafts |
| Q33669553 | Impact of the loss of caveolin-1 on lung mass and cholesterol metabolism in mice with and without the lysosomal cholesterol transporter, Niemann-Pick type C1. |
| Q57374641 | Increased Rho activation and PKC-mediated smooth muscle contractility in the absence of caveolin-1 |
| Q56341347 | Interaction Between Pannexin 1 and Caveolin-1 in Smooth Muscle Can Regulate Blood Pressure |
| Q39674755 | Intracellular retention of glycosylphosphatidyl inositol-linked proteins in caveolin-deficient cells. |
| Q35143923 | Isoform-specific regulation of adenylyl cyclase: a potential target in future pharmacotherapy |
| Q37951442 | Lipid rafts and redox regulation of cellular signaling in cholesterol induced atherosclerosis |
| Q37219869 | Lipodystrophies: disorders of adipose tissue biology |
| Q35281156 | Loss of Caveolin 1 is Associated With the Expression of Aquaporin 1 and Bladder Dysfunction in Mice |
| Q84996864 | Lung defects in neonatal and adult stromal-derived factor–1 conditional knockout mice |
| Q35018010 | MARVEL: a conserved domain involved in membrane apposition events |
| Q37436585 | MMTV promoter-regulated caveolin-1 overexpression yields defective parenchymal epithelia in multiple exocrine organs of transgenic mice |
| Q36322073 | Mammalian PAR-1 determines epithelial lumen polarity by organizing the microtubule cytoskeleton |
| Q35209894 | Membrane dynamics, cholesterol homeostasis, and Alzheimer's disease |
| Q37643632 | Membrane-mediated regulation of vascular identity. |
| Q36888572 | Molecular determinants of endothelial transcytosis and their role in endothelial permeability |
| Q37295085 | Myocardial interstitial Cajal-like cells (ICLC) in caveolin-1 KO mice |
| Q37729860 | New insights into caveolae, caveolins and endothelial function. |
| Q46747841 | Non-canonical roles for caveolin in regulation of membrane repair and mitochondria: implications for stress adaptation with age. |
| Q37492644 | Overexpression of aquaporin-1 and caveolin-1 in the rat urinary bladder urothelium following bladder outlet obstruction |
| Q42091881 | Oxygen dose responsiveness of human fetal airway smooth muscle cells. |
| Q37296289 | Oxygen-mediated endocytosis in cancer |
| Q92243146 | Pathophysiological Role of Caveolae in Hypertension |
| Q37328835 | Prokineticin receptor-1 is a new regulator of endothelial insulin uptake and capillary formation to control insulin sensitivity and cardiovascular and kidney functions. |
| Q34072649 | Regulation of intracellular signaling and function by caveolin |
| Q35584855 | Regulation of tissue factor-factor VIIa expression on cell surfaces: a role for tissue factor-factor VIIa endocytosis |
| Q38344118 | RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells |
| Q57374677 | Role of caveolae in ouabain-induced proliferation of cultured vascular smooth muscle cells of the synthetic phenotype |
| Q35579822 | Role of caveolin and caveolae in insulin signaling and diabetes |
| Q41773292 | Role of caveolin-1 in the regulation of the vascular shear stress response |
| Q35114438 | Sex-dependent expression of caveolin 1 in response to sex steroid hormones is closely associated with development of obesity in rats |
| Q24300651 | Src-induced phosphorylation of caveolin-2 on tyrosine 19. Phospho-caveolin-2 (Tyr(P)19) is localized near focal adhesions, remains associated with lipid rafts/caveolae, but no longer forms a high molecular mass hetero-oligomer with caveolin-1 |
| Q35607385 | Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells |
| Q58271894 | Structural characterization for N‐terminal domain of caveolin‐1 |
| Q51445383 | Subcellular proteomics analysis of different stages of colorectal cancer cell lines. |
| Q40555493 | TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells |
| Q33673772 | Temporal evolution in caveolin 1 methylation levels during human esophageal carcinogenesis |
| Q46641165 | The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endothelium. |
| Q44322989 | The arrangement of cholesterol in membranes and binding of NAP-22. |
| Q36333425 | The association of caveolae, actin, and the dystrophin-glycoprotein complex: a role in smooth muscle phenotype and function? |
| Q21194854 | The caveolin proteins |
| Q35047674 | The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology |
| Q38168916 | The role of caveolae in the pathophysiology of lung diseases |
| Q37162366 | The role of cell cholesterol and the cytoskeleton in the interaction between IK1 and maxi-K channels |
| Q31060466 | Transcription of the caveolin-1 gene is differentially regulated in lung type I epithelial and endothelial cell lines. A role for ETS proteins in epithelial cell expression |
| Q34838964 | Transcriptional repression of Caveolin-1 (CAV1) gene expression by GATA-6 in bladder smooth muscle hypertrophy in mice and human beings |
| Q53535056 | Whole exome sequencing identifies de novo heterozygous CAV1 mutations associated with a novel neonatal onset lipodystrophy syndrome. |
| Q58946639 | eNOS and Caveolin-1 Gene Polymorphisms Interaction and Intima Media Thickness: A Proof of Concept Study in ESRD Patients |
| Q28596004 | rBmαTX14 Increases the Life Span and Promotes the Locomotion of Caenorhabditis Elegans |